Dr Agarwals Health Care Ltd Stock Price Today (NSE: AGARWALEYE)
Fundamental Score
Dr Agarwals Health Care Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Dr Agarwals Health Care Ltd share price today is ₹453.00, up +0.00% on NSE/BSE as of 17 February 2026. Dr Agarwals Health Care Ltd (AGARWALEYE) is a Mid-cap company in the Hospital sector with a market capitalisation of ₹16.84K (Cr). The 52-week high for AGARWALEYE share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 145.15x, AGARWALEYE is currently trading above its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 4.76% and a debt-to-equity ratio of 0.51.
Dr Agarwals Health Care Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Dr Agarwals Health Care Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Dr Agarwals Health Care Share Price: A Conservative Value Investor's Perspective
The Indian hospital sector presents a unique dynamic: rising healthcare awareness is creating a long-term demand tailwind, yet intense competition necessitates operational excellence for sustained profitability. This analysis examines the recent performance of the Dr Agarwals Health Care share price, currently observed at ₹450.149994, through the lens of a conservative value investor prioritizing capital safety. This is part of an 80-parameter fundamental audit verified by Sweta Mishra.
One immediately notes the high Price-to-Earnings (PE) ratio of 145.15. This suggests that the market has very high growth expectations for the company. As a value investor, I would be cautious about paying such a premium, especially when the Return on Capital Employed (ROCE) stands at 9.99%. A higher ROCE is generally preferable, as it indicates the company's efficiency in generating profits from its capital. A lower ROCE, below the current cost of capital, hinders the firm's ability to create or defend an economic moat.
Comparing Dr Agarwals Health Care Ltd. to its peers requires a deeper dive. While financial metrics offer a snapshot, assessing management quality is paramount. For example, when considering
Nephro Care India Limited, scrutinizing factors like capital allocation decisions, transparency with shareholders, and past performance in navigating industry challenges becomes crucial. A company with a track record of prudent financial management and ethical practices is inherently more attractive to a conservative investor.The 9.99% ROCE warrants further scrutiny. While positive, it raises questions about Dr Agarwals Health Care Ltd's ability to reinvest profits at attractive rates to fuel future growth. A low ROCE might suggest that the company operates in a highly competitive environment where returns are compressed, or that it lacks a durable competitive advantage. A value investor would seek to understand the underlying reasons for this ROCE and its potential impact on long-term profitability and capital preservation.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Dr Agarwals Health Care Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AGARWALEYE across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Operating Margins (26.31%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (79.07%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (19.71%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (26.38% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (41.72% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Cash Generation (₹394.15 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 66.05%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Below-Average Return on Equity (4.76%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (9.99%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 145.15x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Dr Agarwals Health Care Ltd Financial Statements
Comprehensive financial data for Dr Agarwals Health Care Ltd including income statement, balance sheet and cash flow
About AGARWALEYE (Dr Agarwals Health Care Ltd)
Dr Agarwals Health Care Ltd (AGARWALEYE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current market capitalisation of ₹16.84K (Cr). Dr Agarwals Health Care Ltd has delivered a Return on Equity (ROE) of 4.76% and a ROCE of 9.99%. The debt-to-equity ratio stands at 0.51, reflecting the company's capital structure. Investors tracking AGARWALEYE share price can monitor key metrics including P/E ratio, promoter holding of 32.42%, and quarterly earnings growth.
Company Details
Key Leadership
AGARWALEYE Share Price: Frequently Asked Questions
What is the current share price of Dr Agarwals Health Care Ltd (AGARWALEYE)?
As of 17 Feb 2026, 10:07 am IST, Dr Agarwals Health Care Ltd share price is ₹453.00. The AGARWALEYE stock has a market capitalisation of ₹16.84K (Cr) on NSE/BSE.
Is AGARWALEYE share price Overvalued or Undervalued?
AGARWALEYE share price is currently trading at a P/E ratio of 145.15x, compared to the industry average of 52.84x. Based on this relative valuation, the Dr Agarwals Health Care Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of AGARWALEYE share price?
The 52-week high of AGARWALEYE share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Dr Agarwals Health Care Ltd share price?
Key factors influencing AGARWALEYE share price include quarterly earnings growth (Sales Growth: 19.71%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Dr Agarwals Health Care Ltd a good stock for long-term investment?
Dr Agarwals Health Care Ltd shows a 5-year Profit Growth of 41.72% and an ROE of 4.76%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.51 before investing in AGARWALEYE shares.
How does Dr Agarwals Health Care Ltd compare with its industry peers?
Dr Agarwals Health Care Ltd competes with major peers in the Hospital. Investors should compare AGARWALEYE share price P/E of 145.15x and ROE of 4.76% against the industry averages to determine competitive standing.
What is the P/E ratio of AGARWALEYE and what does it mean?
AGARWALEYE share price has a P/E ratio of 145.15x compared to the industry average of 52.84x. Investors pay ₹145 for every ₹1 of annual earnings.
How is AGARWALEYE performing according to Bull Run's analysis?
AGARWALEYE has a Bull Run fundamental score of 51.2/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does AGARWALEYE belong to?
AGARWALEYE operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Dr Agarwals Health Care Ltd share price.
What is Return on Equity (ROE) and why is it important for AGARWALEYE?
AGARWALEYE has an ROE of 4.76%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Dr Agarwals Health Care Ltd generates profits from shareholders capital.
How is AGARWALEYE debt-to-equity ratio and what does it indicate?
AGARWALEYE has a debt-to-equity ratio of 0.51, which indicates moderate leverage that should be monitored.
What is AGARWALEYE dividend yield and is it a good dividend stock?
AGARWALEYE offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Dr Agarwals Health Care Ltd shares.
How has AGARWALEYE share price grown over the past 5 years?
AGARWALEYE has achieved 5-year growth rates of: Sales Growth 26.38%, Profit Growth 41.72%, and EPS Growth N/A%.
What is the promoter holding in AGARWALEYE and why does it matter?
Promoters hold 32.42% of AGARWALEYE shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Dr Agarwals Health Care Ltd.
What is AGARWALEYE market capitalisation category?
AGARWALEYE has a market capitalisation of ₹16844 crores, placing it in the Mid-cap category.
How volatile is AGARWALEYE stock?
AGARWALEYE has a beta of N/A. A beta > 1 suggests the Dr Agarwals Health Care Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is AGARWALEYE operating profit margin trend?
AGARWALEYE has a 5-year average Operating Profit Margin (OPM) of 26.31%, indicating the company's operational efficiency.
How is AGARWALEYE quarterly performance?
Recent quarterly performance shows Dr Agarwals Health Care Ltd YoY Sales Growth of 19.71% and YoY Profit Growth of 79.07%.
What is the institutional holding pattern in AGARWALEYE?
AGARWALEYE has FII holding of 58.13% and DII holding of 7.92%. Significant institutional holding often suggests professional confidence in the Dr Agarwals Health Care Ltd stock.